Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-infer... by Brown, Janet E, Prof, Royle, Kara-Louise, MSc, Gregory, Walter, Prof, Ralph, Christy, PhD, Maraveyas, Anthony, Prof, Din, Omar, MD, Eisen, Timothy, Prof, Nathan, Paul, Prof, Powles, Tom, Prof, Griffiths, Richard, FRCP, Jones, Robert, Prof, Vasudev, Naveen, PhD MBChB, Wheater, Matthew, FRCP PhD, Hamid, Abdel, FRCR MSc, Waddell, Tom, MD, McMenemin, Rhona, MSc FRCR, Patel, Poulam, Prof, Larkin, James, Prof, Faust, Guy, MD, Martin, Adam, PhD, Swain, Jayne, PhD, Bestall, Janine, PhD, McCabe, Christopher, Prof, Meads, David, PhD, Goh, Vicky, Prof, Min Wah, Tze, Prof, Brown, Julia, Prof, Hewison, Jenny, Prof, Selby, Peter, Prof, Collinson, Fiona, MD

Get full text